COMPANY NEWS


Alembic Pharmaceuticals Ltd
BSE Code 533573 ISIN Demat INE901L01018 Book Value (₹) 249.74 NSE Symbol APLLTD Div & Yield % 1.14 Market Cap ( Cr.) 19,000.77 P/E * 28.51 EPS * 33.91 Face Value (₹) 2
* Profit to Earning Ratio
* Earning Per Share
Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav Back
(06 May 2024)
Alembic Pharmaceuticals announced that the company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection carried out by them at the company's Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from 28 February 2024 to 8 March 2024.